Discover trends, market shifts, and competitive outlooks for the nephrology drugs industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the Nephrology Drugs Market Size From 2025 to 2034?

In the prior years, there has been significant expansion in the size of the nephrology drugs market. The market, which was valued at $16.88 billion in 2024, is projected to increase to $17.86 billion in 2025, translating to a compound annual growth rate (CAGR) of 5.8%. Several factors contributed to this growth during the historical period. These include the increasing prevalence of chronic kidney diseases (CKD), strides in drug development, heightened awareness and diagnosis, government action, and healthcare policies, as well as the rising incidence of diabetes.

In the coming years, we can anticipate a significant surge in the nephrology drugs market size, which is predicted to reach $23.04 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 6.6%. Contributing factors for this growth over the forecast period include the emergence of innovative therapies and drugs, precision and personalized treatment plans, increased healthcare spending, telehealth, and remote patient services, as well as global health initiatives. Key trends during this period are expected to encompass collaborations, strategic partnerships, technological breakthroughs in dialysis procedures, improvements in treatment strategies, an increased focus on early diagnosis and intervention, and the integration of technology in managing nephrology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10076&type=smp

What Are the Core Market Drivers Propelling Growth in the Nephrology Drugs Industry?

The nephrology drugs market is anticipated to grow due to the increasing occurrence of chronic kidney disease (CKD). CKD involves impaired kidneys that can’t efficiently purify blood as they’re supposed to, as kidney damage unfolds over a long timeframe. This damage could result in the accumulation of wastes within the body. Nephrology drugs are essentially utilized in managing chronic kidney disease to enhance kidney performance and slow down the progression of the condition, preventing further harm to the body. This leads to an increase in the nephrology drugs market. For example, the Centers for Disease Control and Prevention (CDC), a US-based health protection agency, reported in July 2022 that over 37 million people in the US were identified with chronic kidney disease, predominantly affecting individuals aged 65 years or older (38 percent). Additionally, according to the Kidney Foundation of Canada, a Canada-based non-profit entity, around 4 million Canadians are afflicted with kidney diseases. Diabetic patients account for 35 percent as the main cause of kidney failure. These figures are anticipated to increase in the years to come. Hence, the escalating prevalence of chronic kidney disease is fueling the expansion of the nephrology drugs market.

How Is the Nephrology Drugs Market Segmented?

The nephrology drugs market covered in this report is segmented –

1) By Drugs: Antihypertensive Agents, Erythropoiesis-Stimulating Agents, Diuretics, ACE Inhibitors, Antidiabetic Agents, Other Drugs

2) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Antihypertensive Agents: Calcium Channel Blockers, Beta-Blockers, Angiotensin II Receptor Blockers (ARBs)

2) By Erythropoiesis-Stimulating Agents: Epoetin Alfa, Darbepoetin Alfa

3) By Diuretics: Loop Diuretics, Thiazide Diuretics, Potassium-Sparing Diuretics

4) By ACE Inhibitors: Lisinopril, Enalapril

5) By Antidiabetic Agents: Metformin, Insulin

6) By Other Drugs: Phosphate Binders, Vitamin D Analogues, Renin Inhibitors

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10076&type=smp

Which Regions Are Driving the Next Phase of the Nephrology Drugs Market Growth?

North America was the largest region in the nephrology drug market in 2024.Europe will be the second-largest growing region in the nephrology drug market in 2024. The regions covered in the nephrology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Market Trends and Innovations Are Shaping the Future of the Nephrology Drugs Industry?

The advancement of product development is a significant trend rising in the nephrology medication market. Key players in this market are introducing novel products and medications to maintain their market presence. For instance, Zydus Lifesciences Limited., a pharmaceutical firm based in India, released Oxemia (desidustat) for chronic kidney disease (CKD) in March 2022. This orally-administered small-molecule hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor serves as a convenient therapeutic solution for anemia treatment and has been validated by the Drug Controller General of India. In Phase III clinical testing, it showed promising safety records, decreased hepcidin, improved iron mobilization, and a drop in LDL-C among CKD patients. Furthermore, by offering affordable treatment and improving patient’s life quality, this contributes to easing the disease’s impact.

View the full report here:

https://www.thebusinessresearchcompany.com/report/nephrology-drugs-global-market-report

How Is the Nephrology Drugs Market Defined and What Are Its Core Parameters?

Nephrology drugs, also known as renal drugs, refer to medicines related to kidney care. These drugs are often related to high blood pressure and hypertension. It is used to attempt to enhance kidney function and to slow the disease down, preventing it from doing further harm to the body.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10076

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model